It was also reported that SOX2 potentiates an immunosuppressive microenvironment and promotes HNSCC growth in vivo by inhibiting type 1 IFN signaling.[24] Moreover, SOX2+ tumor cells have been identified as CSCs and progenitor cells in SCC. Here, SOX2 is linked to neoplasm.